Carl Zeiss Meditec Reports Decline in Earnings and Revenue

Carl Zeiss Meditec AG has disclosed lower earnings for the first half of the fiscal year 2025/26, with a decline in revenue from €1,050.5 million to €991.0 million, marking a 5.7% decrease. Adjusted EBITA also fell significantly to €60.5 million from €112.6 million. The company attributes this decline primarily to unfavorable currency effects and challenges in the intraocular lens business.

Regionally, the EMEA region showed stability, while the Americas and APAC regions experienced significant downturns, due in part to geopolitical uncertainties. Strategic business units for Ophthalmology and Microsurgery both underperformed compared to the previous year.

The management plans extensive measures to restore profitability, including structural and cost optimizations, expecting an earnings improvement of over €200 million annually by 2028/29. These adjustments will support future investment in growth and innovation.